Establishing a method to estimate the effect of antimyopia management options on lifetime cost of myopia.
Timothy R FrickePadmaja R SankaridurgThomas NaduvilathSerge ResnikoffNina TahhanMingguang HeKevin D FrickPublished in: The British journal of ophthalmology (2022)
Financial investment in AMM during childhood may be balanced or exceeded across a lifetime by reduced refractive progression, simpler lenses, and reduced risk of pathology and vision loss. Our methodology can be applied to estimate cost in comparable scenarios.